CMO/CDMO

Pharma, biotech and the drug delivery industries gather annually at PODD to assess delivery needs, latest trends and information on deals and learn about a wide range of innovative drug delivery technologies that could improve the delivery of various types of drugs. This can include proteins, peptides, oligonucleotides, biologics, and small molecules and more. PODD provides business development opportunities through organized networking and a partnering tool for new, emerging and established collaborations.

Engage in scientific discussions on the latest tools and technologies for accelerated NK-based cellular immunotherapy development. Benefit from exclusive insights from global influencers in NK based cell therapy, addressing strategies for safety, quality control and off-target activity assessment, with the goal to fast track to clinic.

A thorough 2 day event addressing emerging strategies for the drug development of Neuroscience and successful approaches for more targeted, precise, and transformative therapies to neurodegenerative and neuropsychiatric diseases. This in-depth event will detail the journey of neuroscience discovery from initial lead through to clinical trials, bringing together leading companies for discussion, knowledge-sharing.

A two-day event with dedicated streams on the latest tools and technologies for advanced understanding of cell-based products, including optimised cell line development, strategies to overcome bottlenecks and improved efficacy and safety of cell and gene therapies to ensure clinical and commercial product success.

The PDA annual conference provides a forum for sharing knowledge on developing new modalities and the adoption of innovative approaches and processes. You will dive into exciting interactive sessions designed for manufacturing leaders, technical experts/scientists, and early career professionals. No matter what your area of focus, you are sure to come away with tangible and practical solutions to improve your operations

Connecting global pharma, biotech and academia for high-level discussions on the latest innovations in biologics development. Consisting of the Proteins & Antibodies Congress, Bispecifics in Discovery & Development Congress and Peptides & Oligonucleotides Congress, visionary leaders will discuss the current state of the industry, market trends and future growth areas pushing the biologics industry in the future.

The 2023 Annual Meeting & Expo reflects our focus on cutting-edge research and innovation across our strong discipline that will keep you up-to-date with new science and inspire new ideas. Most importantly, this event will offer you the ability to network, form friendships among your peers and foster new collaborations within the delivery science and technology field. We have a full and exciting program over the conference duration with highly prominent plenary talks, technical sessions covering a wide scope of topics, industry led workshops and technical forums.

Our established genomics event will be returning to London this autumn featuring the 15th Annual Next Generation Sequencing & Clinical Diagnostics, 10th Annual Single Cell Analysis, 8th Annual Genome Editing and 4th Annual Digital PCR Congresses. From clinical genomics updates and single cell analysis current & emerging tools, through to genome editing techniques for assessing specificity for on and off targets and applications of digital PCR in oncology, this is the event to attend this fall to stay at the forefront of genomics research.

Featuring focused discussions, presentations, and networking on multi-omic data integration, single cell & spatial analysis, genome editing in drug discovery & development and novel genome editing technologies.

An intensive 2-day in person meeting that delves into the latest in oligonucleotides chemistry, process & analytical development, therapeutics, antisense therapy & a meeting place for experts working within cutting-edge oligo research & therapeutic development. From new and exciting to the latest in products & services, this event will bring together over 150 leading companies for in-depth discussions, knowledge sharing and focused networking. Colocated with the RNA Therapeutics & Delivery Europe: In Person.